Status:
UNKNOWN
Comparision of Different Doses of Dexmedetomidine With Low Dose Bupivacaine in Selective Spinal Anesthesia.
Lead Sponsor:
Services Institute of Medical Sciences, Pakistan
Conditions:
Drug Effect
Eligibility:
MALE
20+ years
Phase:
PHASE4
Brief Summary
The charactereistics of a spinal block varies with the dose of local anaesthetic and the adjuvant used. Literature review did not show comparison of different doses of dexmedetomidine with low-dose bu...
Detailed Description
SYNOPSIS: Comparison of different doses of intra-thecal dexmedetomidine as an additive to low-dose bupivacaine(5mg) in selective spinal anesthesia for transurethral resection of prostate in elderly p...
Eligibility Criteria
Inclusion
- Male gender Age between 50 and 70 years old Patients' physical status by the American Society of Anesthesiologist (ASA): ASA class I, II and III
Exclusion
- Contraindications of spinal anesthesia, Patients who were taking α2-adrenergic agonist or antagonist therapy, Patients who were having labile hypertension, uncontrolled cardiac disease, heart block/dysrhythmia, autoimmune disorders, Communication difficulties, e.g. mental retardation or deafness Allergy to the drug or local anesthetics.
Key Trial Info
Start Date :
September 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2019
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04037774
Start Date
September 2 2019
End Date
November 1 2019
Last Update
August 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Services Institute of Medical Sciences
Lahore, Punjab Province, Pakistan, 042